A woman in her 30s presented with generalised swelling and a right occipital–temporal headache. Examination showed grade 4 papilloedema, and magnetic resonance venography revealed thrombosis of the ...

Lupus is more common in Black people, and symptoms can be different too. Here's what to look out for and how to treat it.

HealthDay News — For patients with systemic lupus erythematosus (SLE), obinutuzumab, a glycoengineered type II anti-CD20 monoclonal antibody, is superior to placebo, according to a study published ...

New analysis of Gazyva® shows the drug significantly reduces disease activity in adults with systemic lupus erythematosus.

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune diseases – by reprogramming patients’ out-of-whack immune ...

While your hair tends to steal the spotlight, the skin underneath is just as important. In some cases, your scalp provides clues about your overall health or an underlying condition — especially if ...

An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant ...

Roche Holding AG ( RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline March 9, 2026 12:00 PM EDT ...

A personal curriculum is a self-directed learning plan focused on interests and growth, not grades, explains columnist Candace Semien.

When the world disappoints us, giving up can feel strategic. Research on “lying flat” suggests it often deepens dissatisfaction. Meaning, not withdrawal, may be the better defense.

Obinutuzumab is a potent anti-B cell drug already approved to treat lupus nephritis, chronic lymphocytic leukemia, and follicular lymphoma. Therapies targeting B cells are perhaps the most effective ...

Now the Vice President of Research at the Lupus Foundation of America, Dr. Buie’s work stems from that curiosity as well as ...